Pain Therapeutics: New Times, New Targets - Biologics Market Research

Pain Therapeutics: New Times, New Targets
Drug and Market Development Publishing
July 1, 2006
312 Pages
Pub ID: DSMD1316511
US $4,950.00 Online Download
US $4,950.00 Hard Copy Mail Delivery
Abstract
D&MD?s new Pain Therapeutics market analysis report focuses on new advances in drug discovery and development. The report provides a background on pain, current therapies and research and development in the area. Profiles of companies with major pain programs include Abbott Laboratories, AstraZeneca, GlaxoSmithKline, GW Pharmaceuticals, Johnson & Johnson, Merck & Co., Neuromed Pharmaceuticals, Novartis, Pfizer, Vernalis, VistaGen Therapeutics, Xenome and more. In-depth interviews with industry leaders provide specific case studies from both biotech and academia that give a sense of what?s really going on in the trenches.